| Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants Y Momozawa, R Sasai, Y Usui, K Shiraishi, Y Iwasaki, Y Taniyama, ... JAMA oncology 8 (6), 871-878, 2022 | 100 | 2022 |
| Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer Y Usui, Y Taniyama, M Endo, YN Koyanagi, Y Kasugai, I Oze, H Ito, ... New England Journal of Medicine 388 (13), 1181-1190, 2023 | 73 | 2023 |
| Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry K Matsue, Y Matsue, K Kumata, Y Usui, Y Suehara, K Fukumoto, ... Hematological Oncology 35 (3), 323-328, 2017 | 32 | 2017 |
| Across-site differences in the mechanism of alcohol-induced digestive tract carcinogenesis: an evaluation by mediation analysis YN Koyanagi, E Suzuki, I Imoto, Y Kasugai, I Oze, T Ugai, M Iwase, Y Usui, ... Cancer research 80 (7), 1601-1610, 2020 | 26 | 2020 |
| Diagnostic and prognostic value of using 18F-FDG PET/CT for the evaluation of bone marrow involvement in peripheral T-cell lymphoma Y Abe, A Kitadate, Y Usui, K Narita, H Kobayashi, D Miura, M Takeuchi, ... Clinical Nuclear Medicine 44 (5), e336-e341, 2019 | 24 | 2019 |
| Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan N Ishikura, Y Usui, H Ito, Y Kasugai, I Oze, S Kato, Y Yatabe, S Nakamura, ... Annals of Hematology 98, 1981-1987, 2019 | 22 | 2019 |
| Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response K Fukumoto, M Fujisawa, Y Suehara, KT Narita, Y Usui, M Takeuchi, ... Leukemia & Lymphoma 57 (8), 1786-1792, 2016 | 18 | 2016 |
| Impact of PSCA polymorphisms on the risk of duodenal ulcer Y Usui, K Matsuo, I Oze, T Ugai, Y Koyanagi, Y Maeda, H Ito, A Hishida, ... Journal of epidemiology 31 (1), 12-20, 2021 | 14 | 2021 |
| Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma Y Suehara, H Takamatsu, K Fukumoto, M Fujisawa, K Narita, Y Usui, ... Cancer science 108 (2), 187-192, 2017 | 14 | 2017 |
| Changing trend in mortality rate of multiple myeloma after introduction of novel agents: a population‐based study Y Usui, H Ito, Y Koyanagi, A Shibata, T Matsuda, K Katanoda, Y Maeda, ... International Journal of Cancer 147 (11), 3102-3109, 2020 | 12 | 2020 |
| Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan M Inoue-Choi, ND Freedman, E Saito, S Tanaka, M Hirabayashi, ... International journal of epidemiology 51 (4), 1276-1290, 2022 | 9 | 2022 |
| Concomitant subcutaneous intravascular lymphoma lesions in a patient with cardiac diffuse large B-cell lymphoma: is intravascular lymphoma a distinct clinical entity? Y Abe, Y Usui, K Narita, M Takeuchi, K Matsue International Journal of Hematology 108, 637-639, 2018 | 6 | 2018 |
| Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL K Kameda, S Kako, SW Kim, Y Usui, K Kato, T Fukuda, N Uchida, ... Leukemia 36 (5), 1361-1370, 2022 | 5 | 2022 |
| Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation S Seo, Y Usui, K Matsuo, Y Atsuta, A Igarashi, T Fukuda, Y Ozawa, ... Bone Marrow Transplantation 56 (10), 2410-2422, 2021 | 5 | 2021 |
| Clinical features, diagnosis, and prognosis of 14 cases of neurolymphomatosis: Single institutional experience over 10 years Y Abe, Y Usui, K Narita, M Takeuchi, K Matsue Blood 128 (22), 3042, 2016 | 5 | 2016 |
| Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk Y Usui, Y Iwasaki, K Matsuo, M Endo, Y Kamatani, M Hirata, K Sugano, ... Cancer Science 113 (11), 3972-3979, 2022 | 4 | 2022 |
| Utility of interim and post-therapy PET/CT in T-cell and NK-cell lymphoma: a single institutional analysis over 9 years K Fukumoto, M Fujisawa, Y Suehara, Y Usui, K Narita, M Takeuchi, ... Blood 126 (23), 3915, 2015 | 3 | 2015 |
| Trends in non‐Hodgkin lymphoma mortality rate in Japan and the United States: A population‐based study Y Usui, H Ito, K Katanoda, T Matsuda, Y Maeda, K Matsuo Cancer Science 114 (10), 4073-4080, 2023 | 2 | 2023 |
| N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in … Y Abe, T Kobayashi, Y Usui, K Narita, H Kobayashi, A Kitadate, D Miura, ... Oncotarget 10 (10), 1160, 2019 | 2 | 2019 |
| Clinical significance of circulating plasma cells in myeloma: multiparameter flow cytometric analysis M Fujisawa, Y Suehara, K Fukumoto, K Narita, Y Usui, M Takeuchi, ... Blood 126 (23), 5352, 2015 | 2 | 2015 |
